We report an extremely rare case of metastatic common bile duct cancer from pulmonary adenocarcinoma presenting as obstructive jaundice. The patient was a 76-year-old male, who presented with generalized weakness and right upper quadrant pain. Plain chest X-ray noted multiple small nodules in both lung fields. Abdominal computed tomography scan showed a stricture of the mid common bile duct along with ductal wall enhancement. Endoscopic retrograde cholangiography revealed a concentric, abrupt narrowing of the mid-common bile duct suggestive of primary bile duct cancer. However, pathology comfirmed metastatic common bile duct cancer arising from pulmonary adenocarcinoma with immunohistochemical study with thyroid transcriptional factor-1 (TTF-1). (Korean J Gastroenterol 2013;61:50-53) 
INTRODUCTION
Malignant distal biliary obstruction is mostly caused by primary bile duct cancer or metastasis of other tumors to the peripancreatic, periportal, peribiliary lymph nodes, and head of the pancreas. 1 Common malignant tumors that could cause metastatic distal biliary obstruction are stomach cancer and colon cancer, but lung cancer rarely causes it. [1] [2] [3] Furthermore, biliary obstruction associated with metastasis to the common bile duct is even rarer in non-biliary cancers, especially in lung cancer.
CASE REPORT
A 76-year-old man presented with generalized weakness, poor oral intake and right upper quadrant pain of 2 months' duration. He was a never smoker. Since he had a history of Billroth-II operation for stomach cancer 12 years ago, surveillance esophagogastroduodenoscopy and screening colonoscopy were performed to rule out gastrointestinal cause of patient's symptoms. However, there was no evidence of stomach cancer recurrence and only one 1.2 cm sized lateral spreading tumor was found on the cecum, which was removed with snare electrocautery. On physical examination, the patient was chronic ill-looking and showed right upper quadrant tenderness. Laboratory evaluation revealed ane- scopy showed hyperemic mucosal change, finding suspicious of cancer cell infiltration (Fig. 4A) . Biopsy also showed invasive nests of adenocarcinoma cells, which were strong positive for TTF-1 (Fig. 4B, C) . Thus, the diagnosis of metastatic common bile duct cancer from pulmonary adenocarcinoma could be made. PET scan revealed metastasis to the bran, L2 lumbar spine, and left supraclavicular lymph node additionally. The patient was referred to the oncologist to undergo systemic chemotherapy after we inserted un-covered biliary metal stent.
DISCUSSION
Patients with primary bile duct cancers typically present with painless jaundice resulting from hilar or distal biliary strictures or with an intrahepatic mass causing abdominal pain. Common non-biliary malignancy that can cause distal biliary obstruction are stomach cancer and colon cancer.
Biliary obstruction caused by lung cancer is rare and mostly due to the compression of the bile duct by metastasis to the surrounding the lymph nodes or to the pancreas head.
More than half of all lung cancer patients present with advanced stage at the time of diagnosis. Extrathoracic metastasis is found at autopsy in more than 50% of patients with squamous carcinoma, 80% of patients with adenocarcinoma, and more than 95% of patients with small cell lung cancer. The most frequent site of extrathoracic spread of lung cancer is to the liver and adrenal gland. TTF-1 is expressed in 26% to 76% of adenocarcinomas, in 0%
to 38% of squamous cell carcinomas, in 40% of large cell carcinomas, in 40% to 75% of large cell neuroendocrine carcinomas, and in 81% to 100% of small cell carcinomas. [8] [9] [10] Thus, it could serve as a reliable marker of primary lung cancer.
bile duct cancer arising from pulmonary adenocarcinoma.
Considering the patient's age, generalized condition, and advanced stage of malignancy irrespective of primary site, immunohistochemical study for localizing primary origin of bile duct stricture might not affect treatment modality and prognosis of the patient. However, If treatment modality such as surgery improves prognosis according to the bile duct histology, we should make every effort to identify the primary origin in patient with bile duct stricture and other lesion including lung. In summary, when it is necessary to differentiate between primary bile duct cancer and metastatic bile duct cancer from pulmonary adenocarcinoma, immunohistochemical study of the biopsy samples from bile duct with TTF-1 can be useful in differential diagnosis.
